DrugsControl Media Services

News Detail

MDC recommends exemption for Panacea Biotec's EasyFourPoI vaccine from DPCO (04-10-2023)

New Delhi, 4 Oct 2023: The Multi-Disciplinary Committee (MDC) of Experts under the National Pharmaceutical Pricing Authority (NPPA) has recommended to grant exemption to Panacea Biotec's EasyFourPoI vaccine, an adsorbed diphtheria, tetanus, pertussis, inactivated poliomyelitis, a......
View Details

Source : Pharmabiz
Multi-Disciplinary Committee MDC NPPA Panacea Biotec EasyFourPoI vaccine diphtheria tetanus pertussis inactivated poliomyelitis haemophilus influenzae type B conjugate vaccine DPCO 2013 Indian Patent Act Universal Immunisation Programme UIP DCGI Para 32 Easy Six

Related News